ÂÜÀòÂÒÂ×

Atul Pande has extensive work experience in the biotechnology and healthcare industry. Atul currently serves as a Non Executive Director for Pangea Botanica, Immunovant, and Perception Neurosciences. At Karuna Therapeutics, they hold the positions of Scientific Advisory Board Member and Non Executive Director. In addition, Atul Pande is a Leadership Council Member at the University of Michigan Life Sciences Institute. Atul has also held positions as a Clinical Advisor at MMS Holdings Inc., Chief Executive Officer at Verity BioConsulting, and Member of the Board of Directors at Autifony Therapeutics Limited. Furthermore, Atul Pande is the Lead Independent Board Director at Sio Gene Therapies. Atul has provided advisory services at MAPS Public Benefit Corporation. With a diverse range of roles and expertise in the field, Atul Pande has demonstrated their commitment to advancing healthcare and biotechnology.

Atul Pande's education history begins with their completion of a Research Fellowship Training in Psychiatry at the University of Michigan Medical School from 1986 to 1987. Prior to this, from 1983 to 1985, they pursued a Postgraduate Specialty Training in Psychiatry through the Psychiatry Residency Program at Western University.

Although their education history does not provide specific details, Atul Pande seems to have received their primary education between 1971 and 1979, as the information specifies no institution or degree obtained during this period.

Furthermore, Atul Pande has obtained a certification as a Certified Specialist in Psychiatry from The Royal College of Physicians and Surgeons of Canada in November 1985.